Chargeurs S.A. (CRI)
Euronext Paris · France · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 7.190 |
|---|---|
| 52-week range | 7.100 – 11.100 |
| Return, 1 month / 3 months | −11.3% / −16.9% |
| Return, 1 year / 3 years | −12.1% / +37.2% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 38.1% |
| Worst drawdown (1 year) | -24.4% |
| Average daily value traded | 0.07M EUR |
| Dividend yield | 20.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Chargeurs is a French industrial group based in Paris that supplies specialised materials and services to manufacturers and brands. Its businesses include protective films used to shield surfaces during handling and transport, interlinings and textile components for clothing makers, and technical substrates for industrial customers. It also works in luxury and fashion-related materials and services. Customers are mainly industrial firms and apparel and luxury brands in Europe and other markets.
The shares are listed on the Euronext Paris in France under the code CRI, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Chargeurs S.A. (CRI) trades on the Euronext Paris in France. It last closed at EUR 7.190 on 22 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 242 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.1% and over the last three months it fell 16.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -8.0% | ||
| From 52-week high | -32.6% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -16.9% | ||
| 6-month return | 3.9% | ||
| 12-month return, skipping the last month | -0.8% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.4% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.07M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 20.9% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −11.3% |
| 3 months | −16.9% |
| 6 months | +3.9% |
| 1 year | −12.1% |
| 3 years | +37.2% |
| 5 years | −62.1% |
Signals
| 50-day / 200-day average | 8.092 / 7.813 |
|---|---|
| Golden / death cross (60 days) | Golden, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.233 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Jun 2026 | EUR 1.5000 |
| 23 Jun 2025 | EUR 0.1300 |
| 2 May 2023 | EUR 0.5400 |
| 14 Sep 2022 | EUR 0.2200 |
| 12 Apr 2022 | EUR 0.7600 |
| 15 Sep 2021 | EUR 0.4800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.